Bristol Myers Squibb (BMY) EBITDA Margin Growth (1y) (2010 - 2026)
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBITDA Margin Growth (1y) (Qtr) |
| 1 |
Novartis Ag |
107,124,802.25 Bn |
107,124,802.25 Bn |
- |
- |
| 2 |
Eli Lilly |
969.00 Bn |
963.72 Bn |
16.22 Bn |
660.00 |
| 3 |
Johnson & Johnson |
539.46 Bn |
517.41 Bn |
15.96 Bn |
-179.00 |
| 4 |
AbbVie |
376.92 Bn |
367.57 Bn |
10.78 Bn |
-138.00 |
| 5 |
Merck |
285.00 Bn |
279.35 Bn |
12.09 Bn |
-6,345.00 |
| 6 |
Amgen |
177.58 Bn |
165.55 Bn |
5.87 Bn |
1,648.00 |
| 7 |
Gilead Sciences |
163.22 Bn |
155.50 Bn |
5.52 Bn |
360.00 |
| 8 |
Pfizer |
145.86 Bn |
133.09 Bn |
-1.21 Bn |
2,760.00 |
| 9 |
Bristol Myers Squibb |
111.90 Bn |
101.44 Bn |
8.07 Bn |
437.00 |
| 10 |
Gsk |
88.34 Bn |
83.66 Bn |
- |
- |
| Date | Value |
| Mar 31, 2026 |
437.00 |
| Dec 31, 2025 |
615.00 |
| Sep 30, 2025 |
826.00 |
| Jun 30, 2025 |
-368.00 |
| Mar 31, 2025 |
11,943.00 |
| Dec 31, 2024 |
-1,064.00 |
| Sep 30, 2024 |
-842.00 |
| Jun 30, 2024 |
-499.00 |
| Mar 31, 2024 |
-11,834.00 |
| Dec 31, 2023 |
-78.00 |
| Sep 30, 2023 |
284.00 |
| Jun 30, 2023 |
435.00 |
| Mar 31, 2023 |
788.00 |
| Dec 31, 2022 |
-722.00 |
| Sep 30, 2022 |
155.00 |
| Jun 30, 2022 |
471.00 |
| Mar 31, 2022 |
-961.00 |
| Dec 31, 2021 |
14,181.00 |
| Sep 30, 2021 |
1,643.00 |
| Jun 30, 2021 |
1,982.00 |
| Mar 31, 2021 |
5,770.00 |
| Dec 31, 2020 |
-8,773.00 |
| Sep 30, 2020 |
502.00 |
| Jun 30, 2020 |
-746.00 |
| Mar 31, 2020 |
-3,941.00 |
| Dec 31, 2019 |
-3,123.00 |
| Sep 30, 2019 |
-1,646.00 |
| Jun 30, 2019 |
1,630.00 |
| Mar 31, 2019 |
-114.00 |
| Dec 31, 2018 |
1,481.00 |
| Sep 30, 2018 |
1,666.00 |
| Jun 30, 2018 |
-1,410.00 |
| Mar 31, 2018 |
-1,024.00 |
| Dec 31, 2017 |
-1,047.00 |
| Sep 30, 2017 |
-1,270.00 |
| Jun 30, 2017 |
-1,372.00 |
| Mar 31, 2017 |
27.00 |
| Dec 31, 2016 |
2,567.00 |
| Sep 30, 2016 |
786.00 |
| Jun 30, 2016 |
3,148.00 |
| Mar 31, 2016 |
-114.00 |
| Dec 31, 2015 |
-767.00 |
| Sep 30, 2015 |
-273.00 |
| Jun 30, 2015 |
-912.00 |
| Mar 31, 2015 |
1,443.00 |
| Dec 31, 2014 |
-1,500.00 |
| Sep 30, 2014 |
881.00 |
| Jun 30, 2014 |
32.00 |
| Mar 31, 2014 |
1,060.00 |
| Dec 31, 2013 |
431.00 |
| Sep 30, 2013 |
5,134.00 |
| Jun 30, 2013 |
-1,009.00 |
| Mar 31, 2013 |
-2,394.00 |
| Dec 31, 2012 |
-1,757.00 |
| Sep 30, 2012 |
-6,803.00 |
| Jun 30, 2012 |
-987.00 |
| Mar 31, 2012 |
533.00 |
| Dec 31, 2011 |
418.00 |
| Sep 30, 2011 |
95.00 |
| Jun 30, 2011 |
-92.00 |
| Mar 31, 2011 |
542.00 |
| Dec 31, 2010 |
223.00 |
| Sep 30, 2010 |
178.00 |
| Jun 30, 2010 |
24.00 |
| Mar 31, 2010 |
234.00 |